BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2007
View Archived Issues
Recent Bayer patents report novel therapeutic agents for urological disorders
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More
New therapeutic strategies for cancer imparted in recent patents
Read More
BENCHMRK studies reveal activity of raltegravir in triple-class resistant HIV
Read More
Interleukin-12 gene therapy safe in phase I ovarian cancer study
Read More
Maraviroc effective in phase IIb/III studies in CCR5-tropic HIV-1
Read More
rAAV HIV vaccine safe, well tolerated in healthy subjects
Read More
Entecavir selects for HIV resistance mutations
Read More
Idenix develops potent and selective anti-HIV agents
Read More
Treatment complete in phase II osteoarthritis study of Indaflex
Read More
MIV-701 begins clinical studies for osteoporosis
Read More
Novartis Consumer Health to copromote Vusion ointment to U.S. pediatricians
Read More
Encouraging proof-of-concept results for PA-325
Read More
Enrollment complete in phase I/II study of ALKS-29 in alcohol dependence
Read More
Financing at TransOral to support Intermezzo NDA filing
Read More
Enrollment completed in phase II study of CTA-018 for psoriasis
Read More
Sinovac updates progress of pandemic influenza vaccine study
Read More
Sunesis studies SNS-032 for advanced B-cell malignancies in clinic
Read More
Phase II study of faropenem in acute otitis media meets primary objective
Read More
Panzem NCD studied with Sutent in metastatic renal cell carcinoma
Read More
Roche's HPV tests accepted for FDA review
Read More
Enrollment completed in phase IIb study of AeroLEF
Read More
Sankyo and Biota license Hovione's inhaler technology for influenza
Read More
Amarin acquires rights to nasal lorazepam for emergency epilepsy seizures
Read More
Target enrollment reached in phase III trials of Puricase
Read More
Flurizan shows benefit in mild Alzheimer's patients
Read More
Topline MERLIN TIMI-36 results for ranolazine
Read More
Moli-1901 improves lung function in cystic fibrosis study
Read More
Lipitor approved for five new indications in heart disease
Read More